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Abstract
Mycoplasma suis, the causative agent of porcine infectious anemia, has never been cultured in vitro and mechanisms by
which it causes disease are poorly understood. Thus, the objective herein was to use whole genome sequencing and
analysis of M. suis to define pathogenicity mechanisms and biochemical pathways. M. suis was harvested from the blood of
an experimentally infected pig. Following DNA extraction and construction of a paired end library, whole-genome
sequencing was performed using GS-FLX (454) and Titanium chemistry. Reads on paired-end constructs were assembled
using GS De Novo Assembler and gaps closed by primer walking; assembly was validated by PFGE. Glimmer and Manatee
Annotation Engine were used to predict and annotate protein-coding sequences (CDS). The M. suis genome consists of a
single, 742,431 bp chromosome with low G+C content of 31.1%. A total of 844 CDS, 3 single copies, unlinked rRNA genes
and 32 tRNAs were identified. Gene homologies and GC skew graph show that M. suis has a typical Mollicutes oriC. The
predicted metabolic pathway is concise, showing evidence of adaptation to blood environment. M. suis is a glycolytic
species, obtaining energy through sugars fermentation and ATP-synthase. The pentose-phosphate pathway, metabolism of
cofactors and vitamins, pyruvate dehydrogenase and NAD
+ kinase are missing. Thus, ribose, NADH, NADPH and coenzyme A
are possibly essential for its growth. M. suis can generate purines from hypoxanthine, which is secreted by RBCs, and
cytidine nucleotides from uracil. Toxins orthologs were not identified. We suggest that M. suis may cause disease by
scavenging and competing for host’ nutrients, leading to decreased life-span of RBCs. In summary, genome analysis shows
that M. suis is dependent on host cell metabolism and this characteristic is likely to be linked to its pathogenicity. The
prediction of essential nutrients will aid the development of in vitro cultivation systems.
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Introduction
Eperythrozoon and Haemobartonella organisms were first described
in Germany in the 1920’s [1,2]. Their small size, erythrocyte
parasitism, gram-negative staining and putative arthropod trans-
mission led to their initial classification within the Anaplasmataceae
family, Ricketsialles order [3]. However, in 1997 the 16S risobo-
mal RNA (rRNA) gene sequences of some of these organisms
(Eperythrozoon suis, Eperythrozoon wenyonii, Haemobartonella muris and
Haemobartonella felis) were sequenced and phylogenetically analyzed
[4,5]. Surprisingly, these bacteria showed close homology to
members of the Mycoplasma genus, in the Mycoplasmataceae family,
Mollicute class. An official proposal for reclassification of these four
organisms was published in 2001 [6] and subsequent analyses of
other Haemobartonella and Eperythrozoon organisms revealed that
these organisms were also members of the Mycoplasma genus [7].
Since their taxonomic change, several novel hemotropic myco-
plasmas (hemoplasmas) species have been detected in various
mammals and they comprise a distinctive group within a genus
that was previously known only as mucosal or joint parasites [8].
The causative agent of the porcine infectious anemia (Eperyth-
rozoonosis), Eperythrozoon suis, was initially described in the early
1930’s in the United States, but in 2001, it was reclassified
as Mycoplasma suis [6,9]. This organism has been described in
domestic pigs in South and North America, Europe and Asia [10–
12, Guimaraes et al., unpublished data]. Pathogenicity studies
involving this bacterium have been hampered mainly due to an
inability to cultivate the hemoplasmas in vitro. Observations from
field and experimental infection of pigs suggest that there are two
forms of disease: an acute stage with severe hemolytic anemia or a
chronic form with poorly defined clinical signs. Both disease
forms have been reported on commercial pig farms [10,13–16].
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possible due to the addition of subtherapeutic levels of tetracycline
in the feed. Reproductive problems in sows and reduced weight
gain in feeder pigs have been associated with this form of infection
[13–16]. The acute disease is mainly observed in suckling pigs and
in animals suffering from an immunosuppressive event [17,18].
The acute form of the disease cannot be experimentally induced in
healthy pigs unless they are immunosuppressed or splenectomized.
However, splenectomy of a chronically infected pig will lead to an
acute, fulminating disease.
Although M. suis was recognized as a pathogen of pigs over 80
years ago, little has been done to better understand its virulence
and mechanisms of pathogenicity, nor to understand what factors
are needed for its survival. Cellular adhesins that mediates
the specific attachment M. suis to swine red blood cells and
the molecular basis of adherence has not been fully studied. In
addition, there are no reports detailing the surface architecture
of M. suis. This study was undertaken as the first step toward
understanding the mechanisms by which M. suis causes disease
and establishes chronic infection, as well as to gain new insights
into the biochemical pathways that permit its survival and growth
in vitro. Herein, we present the whole genome sequence of M. suis
strain Illinois and its computational analysis.
Results and Discussion
General genome features
The general genome features of the M. suis strain Illinois are
shown in Table 1 and Figure 1. Its genome consists of a single,
circular chromosome of 742,431 bp with an overall G+C content
of 31.1 mol%. A total of 3 ribosomal RNA (rRNA) genes and 32
transfer RNAs (tRNA) were identified. The rRNA genes were
found in single copies and unlinked; the 23S and the 5S are
organized as an operon and the 16S rRNA is located 166 kb
downstream of these genes. This same organization was described
only in Mycoplasma gallisepticum; however, an additional operon
containing all three rRNA genes was also identified [19]. Thus, so
far, the presence of a single 16S rRNA gene unlinked to the other
rRNAs is a unique feature of M. suis.
The 32 identified tRNAS cover all 20 amino acids and it is
within the range for numbers reported in the 41 available Mollicutes
genomes in NCBI (from 28 to 38 tRNAs). As described for other
mycoplasmas, the UGA in the M. suis genome is likely to be used
as a tryptophan codon; however, a tRNA for selenocysteine [20],
which also uses the ‘stop’ codon UGA, was identified. This Sec-
tRNA has been described in 6 other mycoplasmas (M. genitalium,
M. gallisepticum, M. capricolum, M. hyorhinis, M. crocodyli, M. alligatoris),
however its use versus the Trp-tRNA is still unclear.
Coding DNA sequences (CDS)
A total of 844 CDSs were predicted. The genes comprise 89.9%
of the genome, which is a percentage comparable to that of other
mycoplasmas. However, the average gene length of 783 bp for M.
suis is comparable only to Phytoplasma organisms and consider-
ably less than that reported for other mycoplasmas (Table 1). The
gene length is also similar to some ricketsia, such as Anaplasma
phagocytophilum (775 bp), Neoricketssia sennetsu (804 bp), Ehrlichia
chaffensis (840 bp) and Wolbachia pipientis (855 bp) [21]. It is
noteworthy to mention that, due to the high specificity given by
the long-orfs training of Glimmer, very small CDS (approximately
90–120 nucleotides) with no homologs in the GenBank or paralogs
in the M. suis genome may be missing. This implies that the
average gene length could be even shorter. In the absence of
experimental evidence, these CDSs remain to be added.
Table 1. General features of Mycoplasma suis genome compared to members of pneumoniae, hominis and mycoides
phylogenetic groups of Mycoplasma, and Acholeplasma and Phytoplasma.
Pneumoniae group Hominis group
Mycoides
group
Anaeroplasma and
Phytoplasma groups
Parameter Msu Mpn Mgal-Rl Mge Upa Mho Mhy-J Msy Mpu Mmy Ala Pas*
Genome (bp) 742,431 816,394 1,012,800 580,076 751,719 665,445 897,405 799,476 963,879 1,211,703 1,496,992 860,631
G+C content (%) 31.1 40 31 31.7 25.5 27.1 28 28 26.6 24 31 28
CDS 844 677 742 475 613 537 679 694 782 985 1,380 754
Gene density (%) 89.9% 88.7 91 90 93 89.8 88 91 91.4 83 90 73
Average CDS
length (bp)
783 1011 1,206 1,040 1,116 1,107 1,178 1,058 1,115 982 981 785
CDS with predicted
function
293
(34.7%)
333
(49%)
469
(63%)
323
(68%)
325
(53%)
345
(64%)
412
(60%)
464
(67%)
486
(62%)
581
(59%)
1,006
(73%)
446
(59%)
Conserved
hypothetical CDS
34
(4.0%)
181
(27%)
150
(20%)
56
(12%)
116
(19%)
86
(16%)
109
(16%)
167
(24%)
92
(12%)
138
(14%)
NR 51
(7%)
Hypothetical
CDS
517
(61.3%)
163
(24%)
123
(17%)
96
(20%)
172
(28%)
106
(20%)
158
(24%)
63
(9%)
204
(26%)
266
(27%)
NR 257
(34%)
No. of tRNAs 32 39 33 40 33 33 30 34 29 30 35 32
No. of rRNAs
1 6 S 1 12 1 221212 2 2
2 3 S 1 12 1 221212 2 2
5 S 1 12 1 221312 2 2
*‘Candidatus Phytoplasma asteris’ has two plasmids, EcOYM with 5,025 bp and pOYM with 3,932 bp. Msu=M. suis, Mpn=M. pneumoniae, Mgal-Rl=M. galliseptcium
strain R-low, Mge=M. genitalium, Upa=Ureaplasma parvum serovar 3, Mho=M. hominis, Mhy-J=M. hyopneumoniae strain J, Msy=M. synoviae, Mpu=M. pulmonis,
Mmy=M. mycoides subsp mycoides, Ala=Acholeplasma laidlawii,P a s=‘ Candidatus Phytoplasma asteris’. NR=not reported.
doi:10.1371/journal.pone.0019574.t001
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the CDS; 517 (61.3%) of the CDS were hypothetical proteins
whereas 34 (4.0%) were conserved hypothetical proteins. Of these
34 conserved hypothetical proteins, 17 were unique to M. suis and
M. haemofelis. Remarkably, the proportion of hypothetical proteins
in the M. suis genome greatly exceeds the proportion of these
proteins in other Mollicutes (Table 1) and other blood-borne
pathogens [21,22]. This fact highlights the divergence of the
hemoplasma genome when compared to other Mollicutes. Being a
wall-less bacteria in a blood environment, hemotropic mycoplas-
mas probably developed special mechanisms for survival in this
environment, most of which are still unknown.
Origin of replication
The origin of replication (oriC) of only a few Mollicutes has been
experimentally validated [23–26]. These experiments in other
bacteria have generally shown that the oriC is located in the
vicinity of the dnaA gene and contains dnaA boxes. Thus, this
information and the GC-skew graph have been used to predict
origins of replication [19,27,28]. Assessment of the oriCs in the
available mycoplasma genomes reveals variations in their gene
organization, but a key signature includes the tandem arrange-
ment of dnaA and dnaN genes; M. pneumoniae, M. genitalium and M.
gallisepticum are the only available genomes in which these genes
are not together. Therefore, the M. suis oriC was identified based
Figure 1. Circular diagram of functional assignments of the Mycoplasma suis genome. Starting from the outside, the first circle shows CDSs
in the positive strand. Second circle shows CDSs in the negative strand. The third circle shows the 9 largest hypothetical paralogous gene families;
colors indicate relationships and do not correlate to functional assignments. Black and red tick marks on the third circle represent the 16S rRNA gene
and the 23S/5S rRNA gene operon, respectively. The fourth circle shows the GC skew ([G2C]/[G+C]). The dnaA gene is at position 1. Functional
assignments are related to TIGR roles. The figure was generated using DNAPlotter version 1.3 from Artemis 12.0, Sanger Institute.
doi:10.1371/journal.pone.0019574.g001
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findings. The gene organization of the putative oriC is shown in
Figure 2. As observed in six other mycoplasmas and in Escherichia
coli, both dnaA and dnaN in M. suis were found in tandem
arrangement and the ribosomal protein L34 (rpmH gene) was
located in an opposite direction upstream of dnaA. The GC-skew
graph (Figure 1) shows a significant inversion upstream of the dnaA
and 6 putative dnaA boxes were located near the same gene,
providing additional evidence that the origin of replication can be
annotated in this region of the genome. In addition, the region
between the dnaA and the rpmH gene comprises 134 nucleotides
and its GC content is only 17.9%, which is considered a distinctive
characteristic of the oriC in prokaryotes [29].
Metabolic pathways
Energy metabolism. The predicted metabolic pathways of
M. suis are shown in Figure S1 (Table S1 and S2). Mycoplasmas
generate ATP by the fermentation of sugars, the oxidation of
organic acids (pyruvate and lactate) to acetate plus CO2, the
hydrolysis of arginine, the proton-translocating ATP synthase, or
by combinations of these reactions [30,31]. Mycoplasma suis is a
glycolytic species, relying on the generation of energy through
fermentation of sugars and ATP-synthase. Accordingly, all enzymes
from the Embden-Meyerhoff-Parnas (EMP or glycolysis) pathway
as well as F1F0 ATP synthase are present in the genome of M. suis.
Orthologs to enzymes of the arginine hydrolysis pathway and
dihydroxyacetone kinase are absent. Thus, the ATP synthesis
through arginine hydrolysis or dephosphorylation of dihydroxyacetone
phosphate does not occur in this organism.
Interestingly, the pyruvate metabolism in M. suis is incomplete;
only an ortholog for lactate dehydrogenase was found. Thus, the
production of ATP from the oxidation of pyruvate to acetate is
unlikely, given that the pyruvate dehydrogenase complex and the
acetate kinase are missing. Ureaplasma parvum and U. urealyticum
genome also do not contain an ortholog for the pyruvate
dehydrogenase complex, but activity of this enzyme has been
described in U. urealyticum [cited in 32]. Although pyruvate
dehydrogenase was reported in a proteomic study based on 2D
gels and MALDI-TOF analysis of M. suis [33], the absence of
coenzyme A (CoA) further supports the lack of this enzyme in the
genome of M. suis. Another possibility is that this organism
acquires CoA from its environment. Thus, based on the genome
analysis, M. suis can only oxidize pyruvate through lactate
dehydrogenase, which regenerates NAD
+. Lactate may represent
a possible toxic end-product. It is possible that the balance of
reducing power is regulated by the rate of this reaction, which may
be higher during anaerobic conditions [30].
Pentose phosphate pathway. The pentose phosphate (PP)
pathway in mycoplasmas is considered to be incomplete, but
functional [34]. However, the whole pathway is apparently absent
in M. suis. This feature has been described in Phytoplasma spp. and
is believed to be a result of reductive evolution due to life in an
intracellular nutrient-rich environment [35]. Similarly, M. suis is
also present in a nutrient-rich environment, so that it can acquire
metabolites from plasma and red blood cells, and perhaps even
intracellularly, as recent evidence suggests [36].
In the absence of a PP pathway, M. suis must use alternative
mechanisms to generate NADPH. The absence of NAD
+ kinase
also impairs the interconversion of NADH and NAPDH in the
cell. At least to partially circumvent this problem, M. suis has a
non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase
(GAPN) (Figure S1). This enzyme is responsible for an irreversible
reaction between glyceraldehyde-3-phosphate and 3-phosphoglyc-
erate that reduces NADP to NADPH and has been described in
some mycoplasmas and a few other bacterial species [37,38]. It is
believed that GAPN can preserve the production of NADPH
in bacteria lacking some of the PPP enzymes [39]. Another
explanation for the presence of a GAPN in M. suis is that it might
be used to maintain glycolysis in conditions of ADP and inorganic
phosphate (Pi) depletion and hydrogen peroxide exposure.
GAPN is considered more resistant to hydrogen peroxide than
the phosphorylating glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) [40]. Since reactive oxygen species are continuously
produced within red blood cells, oxidative stress to this cell and by
extension to M. suis is likely high [41]. The use of GAPN may be
related to selective pressures imposed on M. suis by its dependence
on a red cell niche.
The lack of a PP pathway also provides clues for designing a
media to support the in vitro cultivation of M. suis. In the absence of
these enzymes, pentoses for DNA and RNA synthesis cannot be
produced. In contrast to M. pneumoniae [34], ribose is likely to be an
essential nutrient for the survival of M. suis. This feature would
imply that a ribose kinase is present in M. suis. Although an
ortholog of ribose kinase is missing in mycoplasmas, including the
M. suis, its activity has been recently described in M. pneumoniae
[34]. Interestingly, an ortholog of the ribose/galactose importer
was not identified; M. suis may import this sugar through another
ABC-transporter for which the specificity is not yet described.
Nucleotide synthesis. Possibly all Mollicutes are unable to
synthesize de novo purine and pyrimidine bases [31,42] and rather
rely on importing them from the environment. Yus et al. [34]
determined that adenine and guanine are essential for M. pneumoniae
growth whereas cytidine was sufficient for pyrimidine synthesis. In
M. suis, enzymes for the metabolism of inosine monophosphate are
present; thus, it is predicted that hypoxanthine scavenged from the
environment is sufficient for the synthesis of all purine nucleotides
(Figure S1). This is somewhat interesting given the fact that
hypoxanthine is essential for Plasmodium falciparum growth in vitro and
the major purine present in the blood of mammals [43–45].
Hypoxanthine is secreted as an end product from red blood cell
nucleotide metabolism [44,45], providing a ready source for M. suis
to import it from the plasma.
For the pyrimidine metabolism of M. suis, uracil is likely to
provide cytosine nucleotides whereas thymine and/or thymidine
are probably needed (the absence of a thymidylate synthase
impairs the production of thymine nucleotides from dUMP/
Figure 2. Putative gene organization of the origin of replication of Mycoplasma suis. The dnaA boxes were initially localized using the Ori
Finder software (Gao and Zhang, 2008) and annotated based on the consensus sequence 59 – TTWTMHAMA – 39 (Papazisi et al., 2003). One base
mismatch was allowed. hyp=hypothetical protein. X=dnaA boxes.
doi:10.1371/journal.pone.0019574.g002
The Complete Genome of Mycoplasma suis
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19574uracil). This implies the use of a phosphofructokinase for the
conversion of cytidine tirphosphate (CTP) to deoxycytidine
diphosphate (CDP) (Figure S1). Some glycolytic enzymes (pyruvate
kinase, phosphofructokinase, acetate kinase and phosphoglycerate
kinase) have been shown to exert this function in M. genitalium, M.
pneumoniae, M. fermentans and M. capricolum subsp. capricolum [46].
Alternatively, M. suis may require CTP or CDP for growth.
Finally, the pyruvate kinase present in the genome of M. suis is
proposed to be used in the conversion of all NDP and dNDP to
NTP and dNTP, respectively (Figure S1) [34,46].
Lipid and coenzyme A metabolisms. The lipid metabolism
constituted the greatest challenge in the prediction of M. suis’
metabolic pathways. Similarly, this pathway has been poorly
described in mycoplasmas and not all enzymes are identified
[34,47]. The existence of some enzymes is inferred due to the
presence of others and the presence of end-products. In the M. suis
genome, most of the enzymes for the lipid and coenzyme A
metabolisms are absent. To circumvent some of the reaction gaps,
proteins identified in a M. suis proteomic study described
elsewhere were used [48]. The result is a similar phospholipid
biosynthesis pathway as described for M. pneumoniae [34], but still,
several enzymes remain to be found and/or identified.
Lipids are major constituents of cell membranes. There are
three kinds of membrane lipids: phospholipids, glycolipids and
sterol. As described for most mycoplasmas [31], M. suis is
incapable of fatty acid biosynthesis from acetyl-CoA, an important
precursor for membrane lipids. This feature is rare among
eubacteria, but is characteristic of a reduced genome and
increased dependance on host cell nutrients [31]. Phospholipids
and glycolipids are thus believed to be synthesized from glycerol.
Although an ortholog for the glycerol uptake facilitator protein
(GlpF) is absent, the presence of enzymes scattered throughout the
pathway suggests that M. suis uses glycerol, as well as fructose, to
generate phospholipids (cardiolipin). Given the presence of a
choline kinase, it is also possible that phosphatidylcholine is
synthesized. The pathway for synthesis of glycolipids appears to be
missing; all enzymes involved in the synthesis of glycolipids from
phosphatidate and enzymes that provide UDP glucose/galactoase
as substrate for these reactions are absent.
In M. suis, no orthologs for the seven possible enzymes in CoA
metabolism [34] are found. The acyl carrier protein (ACP) and
enzymes directly involved in its metabolism (ACP synthase, ACP
phosphodiesterase, ACP ligase) are typically found in the available
mycoplasma genomes. The absence of ACP and ACP synthase has
been described only in M. hyopneumoniae (all three sequenced
strains). Likewise, M. hominis does not have an ACP, but has an
ACP synthase, and all other mollicutes, except for Acholeplasma
laidlawii, ureaplasmas and phytoplasmas, have an ACP phospho-
diesterase. Thus, M. suis is incapable of using pantothenate for
acylation and CoA synthesis. An alternative means of acylation is
possibly used in its lipid metabolism.
The described findings suggest that M. suis is likely to synthesize
phosphatidylglycerol and cardiolipin from exogenous fatty acids
and use them as major constituents of the plasma membrane;
however, the biosynthetic pathway needs to be thoroughly
validated once this organism can be cultured in vitro. If gaps
cannot be filled by enzymes, yet to be described, the possibility
that M. suis requires exogenous phospholipids and glycolypids is
also plausible. Sterol synthesis does not occur in M. suis and thus it
is possible, as with other mycoplasmas [49,50], that this molecule
is essential for its growth.
Amino acid metabolism. M. suis is unable to synthesize any
amino acid, which is typical of mycoplasmas. Yus et al. [34] have
recently shown that M. pneumoniae requires both peptide (peptone)
and free amino acids to achieve optimal growth. Since amino acids
transporters are few, amino acids need to be supplied in excess to
counteract any competition for transporters; peptides can serve as
an alternative source of amino acids following intracellular
digestion [34]. In the genome of M. suis genome only one
transporter, an amino acid permease, related to the transport of
amino acids, was identified. While the putative transporter for
importation of peptides, the opp ABC peptide transporter, was not
found in the genome of M. suis, it is possible that this function is
performed by another of the ABC transporters.
Vitamin metabolism. Mycoplasmas are not capable of
synthesizing vitamins and need to import them from their
environment. It is still unclear, however, which vitamins are
essential for the growth of these organisms. Although removing
vitamins does not greatly affect in vitro growth of M. pneumoniae, all
nine vitamins tested enhanced its growth [34]. Nicotinic acid
and riboflavin have been described as essential nutrients for
spiroplasma growth [51]. Vitamins from Eagle’s minimal essential
media (folic acid, nicotinamide, riboflavin, cobalamine) also
positively influenced growth of ureaplasmas, but were not
essential [52]. Since M. suis has ABC transporters for spermine/
putrescine and cobalamines, these vitamins are likely to be needed
for its survival.
Orthologs for all nine genes involved in folate metabolism are
absent in M. suis. Further, glycine hydroxymethyltransferase was
not found. Thus, it appears that M. suis cannot interconvert serine
and glycine and must acquire both from the environment. M. suis
also has an incomplete nicotinate pathway. The enzyme nicotinate
phosphoribosyltransferase (PncB), the first committed enzyme in
this pathway, has a nonsense mutation followed by a frameshift
mutation that may impair or completely ablate its activity. Two
additional CDSs related to the NAD metabolism were found:
nicotinamide-nucleotide adenylyltransferase (nadD), the second
enzyme in the pathway, and a phosphohydrolase having a partial
NadD domain and unknown function. Nevertheless, NAD
+
synthase and NAD
+ kinase are missing. Interestingly, a NAD
+
kinase is present in M. haemofelis (Santos et al., unpublished).
Whether or not M. suis can produce NAD
+/NADH is unknown;
however, the absence of NAD
+ kinase implies that NADPH
cannot be generated and thus the organism may get it from
external sources.
DNA metabolism and repair. At least 28 CDSs in the
genome of M. suis are likely to be involved in restriction-
modification (R-M) systems. One putative type I R-M system
(hsdR/hsdM/hsdS) locus was found along with several orphan
hsd genes scattered throughout the genome. It is unclear if
these orphan genes are functional. A type II cytosine-specific
methyltransferase, a S-adenosyl-methyltransferase (MraW), a
DNA methylase N-4/N-6 domain-containing protein, and a type
II restriction enzyme (DpnII) were found in single copies. Among
nucleases, endonuclease IV, ribonuclease p, two ribonuclease
r and ribonuclease HIII were identified. As expected [53], a
thioredoxin reductase system was also found (thioredoxin and
thioredoxin reductase).
Transporters. Overall, mycoplasmas have fewer transport-
ers than other bacteria [22]. It has been suggested that this
reduction has been compensated by using transports with broad
substrate specificity [54]. Only 31 (3.65%) of the M. suis CDSs
comprise transport systems, which is less than that reported for
other mycoplasmas (6.8% to 13.4%) [19,27,55]. As expected [55],
ABC systems-related sequences represent 74.19% (23/31) of all
transporter CDSs. The low number of genes devoted to the
transport of nutrients indicates two possibilities: these transport
systems may have broad substrate specificities and/or other
The Complete Genome of Mycoplasma suis
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the plasma membrane.
Virulence and pathogenicity mechanisms
The current pathogenesis model for anemia due to hemoplasma
infection is based mostly on extravascular hemolysis in the spleen,
liver, lungs and bone marrow [18,56,57]. It is also believed
that an increased osmotic fragility of the erythrocytes caused by
hemoplasma attachment may lead to an intravascular hemolysis
[58]. There is, however, no genetic evidence provided in this study
to support a direct attack on red blood cells leading to its lysis.
Thus, no bacterial toxins, orthologs of hemolysins, hemagglutinins
or other related sequences could be found in the genome of M.
suis. It is still possible that an immune mediated destruction of red
blood cells may exacerbate the anemia through molecular mimicry
and/or exposure of hidden cytoskeletal proteins of erythrocytes
[59].
While attachment to the red blood cell may lead to mechanical
and/or osmotic damage, the extensive scavenging of nutrients
from the host cells by M. suis is also likely to play an important role
in accelerating the removal of infected cells. A novel model for
acute disease due to M. suis infection is proposed based on our
genetic evidence: M. suis competes for and scavenges glucose,
inosine, hypoxanthine, amino acids, NADH/NADPH and ribose
from the host cell. Thus, the reducing power and energy
production (NADH, NADPH, 2,3-DPG, ATP and glutathione
disulfide) of the red blood cells is compromised. Consequently,
there is increased oxidant stress on the red cell and its life span is
shortened, which leads to their premature removal from the
circulation and anemia develops. It is still unclear how M. suis
acquires metabolic compounds from inside the host cell, however
invasion of the erythrocyte [36] might aid in this process.
In a search for additional virulence factors of M. suis, some
adhesins, heat-shock proteins, lipoproteins, protein antigens and
proteases were identified. Three orthologs of proteins involved in
adhesion were found, including at least two MgPa (DHH family
phosphoesterase protein) orthologs and the previously described
M. suis adhesin G1 [33]. Although one of the putative MgPa
proteins has an approximate full length match to known MgPa
proteins in the GenBank databases, the other MgPa has 140
additional amino acids at the C-terminal. MgPa proteins have
been initially described as part of a tip organelle structure
responsible for surface adhesion and possibly motility in M.
genitalium [60,61]. However, M. suis does not have other proteins
that are part of this organelle, such as the accessory proteins of the
group Hmw and the MgPa adhesin (adhesin P1). This observation
is consistent with electron microscopy analyses of M. suis, in which
tip-like structures were not observed [62]. While every available
mycoplasma seems to have orthologs to MgPa (DHH family
phosphoesterase protein), its function in those lacking a tip-
structure is unknown.
Heat-shock proteins have been described as virulence factors in
prokaryotes [63]. Those identified in M. suis include DnaJ, DnaK,
and GrpE. DnaK has been previously reported as an immuno-
reactive protein of M. suis [33]. Interestingly, an ortholog for the
chaperonin GroEL was not found, however this protein was
previously described using 2D gel electhrophoresis and MALDI-
TOF analysis of M. suis [33]. It is possible that one of the
hypothetical proteins of M. suis has a similar molecular weight, pI
and function, but the protein sequence similarity is not enough to
generate significant results. On the other hand, not all Mollicutes
have GroEL, and perhaps this chaperone also has been lost from
the genome of M. suis. A role for selective immunologic pressures
in the loss of this protein in other bacteria has been suggested [64].
In order to assess possible similarities in virulence factors among
mycoplasmas that infect pigs, we compared the CDSs of M. suis to
known adhesins and antigens of M. hyopneumoniae and M. hyorhinis.
The genomes of three strains of M. hyopneumoniae have been
completely sequenced, annotated and analyzed (strains J, 7448
and 232), whereas, the sequenced genome of M. hyorhinis has not
yet been analyzed. There are no available protein sequences of
known antigens/adhesins of M. flocullare and M. hyosynoviae, which
are also known to infect pigs. In addition to the MgPa and heat-
shock proteins described above, a CDS matching the R2 repetitive
motif of the P97 adhesin of M. hyopneumoniae was identified in the
genome of M. suis. This motif is responsible for extracellular
matrix binding [65], however it is also repeatedly present in
protein KIAA1398 of the pig genome (Sus scrofa, accession number
001926148.1); the function of this protein is unknown. A shorter
homolog to KIAA1398 in the dog genome (Canis lupus familiaris),
which contains the same motif, has ribosome binding capabilities
and may mediate the interaction between the ribosome and the
endoplasmic reticulum membrane [66]. While the relationship
between this motif/protein and erythrocyte parasitism is unclear,
experimental analysis of this protein is currently underway in our
laboratory. Other antigens/adhesins, such as the variable
lipoproteins (vlp) of M. hyorhinis, were not found in the M. suis
genome. The lactate dehydrogenase (Ldh), a housekeeping gene
known to be specifically immunogenic in M. hyopneumoniae [67], is
also present in M. suis. Whether or not the M. suis Ldh is
immunogenic, or serum from M. suis infected animals cross-react
with the M. hyopneumoniae Ldh, remains to be elucidated.
The survey for lipoproteins using the LipoP 1.0 algorithm
resulted in the identification of only 3 lipoproteins. In addition,
orthologs for prolipoprotein diacylglycerol transferase, signal
peptidase II, and transacylase were not found in the genome of
M. suis. This is somewhat surprising given that all mycoplasmas
sequenced to date have orthologs to most of these enzymes as well
as several lipoproteins predicted by the same LipoP algorithm.
Taken together, these findings may indicate the use of a different
lipoprotein cleavage/synthesis mechanism by M. suis. Conse-
quently, we are unable to correctly identify lipoproteins as they
may have divergent lipoboxes. Given the presence of secY and secA
genes in M. suis, these proteins are likely to be secreted through the
Sec pathway. However, it is noteworthy that the signal peptidase
I is also absent. This feature has been observed in other
mycoplasmas and may further suggest these organisms have a
different mechanism of protein cleavage [68].
Cytoplasmic and transmembrane proteases are crucial for
survival and pathogenesis of bacteria. Transmembrane proteases
may be used to acquire metabolic precursors from the host,
inactivate host cell defense proteins, and participate in tissue
degradation. However, only two transmembrane proteases of M.
suis were detected: the metalloproteases CAAX amino terminal
protease and ATP-dependent protease FtsH. CCAX amino
terminal protease is involved in cleavage of the AAX tripeptide
in the C-terminal of proteins and likely to be related to protein
and/or peptide modification and secretion [69]. FtsH is a
pleiotropic protein required for correct cell division in bacteria.
An o-sialoglycoprotein endopeptidase ortholog was detected in
the M. suis genome. This enzyme, as described in Mannheimia
haemolytica, may be involved in erythrocyte lysis, resulting from
cleavage of o-sialoglycosylated proteins such as glycophorin A [70].
Although there is experimental evidence that this enzyme has
extracellular activity in M. haemolytica [70], both PSORTb and
SignalP algorithms predict it as cytoplasmic and non-secretory in
mycoplasmas, including M. suis, and in M. haemolytica. The
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elucidated in mycoplasmas.
Paralogous gene families
Many mycoplasmas have developed multi-gene families as a
resource for antigenic diversity and means to avoid clearance by
the host’s immune system [71]. Variations in the number of
paralogous genes in each family may also be related to increased
virulence of specific bacterial strains [72,73]. Sixty-nine para-
logous gene families in M. suis comprising 365 CDSs (42.82%)
were identified. The number of family members for each of the
paralogs ranged from 2 to 37. This result is more than that
reported in M. penetrans, in which 264/1038 (25.4%) of the
predicted CDS were found in paralogous families [74]. While the
large number of paralogs constitutes a plausible explanation for
the large genome size of M. penetrans (1,358,633 bp), this isn’t the
case for M. suis, which is relatively small. All families, except for
8/69 (11.6%), were hypothetical proteins. The eight known
families included 4 families of type I restriction system (n=11, 6,
4 and 4) and 1 family each for the cobalt import ATP-binding
protein CbiO (n=2), DNA binding protein (n=2), ATP synthase
C subunit (n=2), and Dna polymerase I (n=2). Members of the
four largest families (n=37, 20, 16 and 13), all of which are
hypothetical proteins, are clustered together in the genome
(Figure 1), probably arising from in tandem duplication events.
Additional evaluation of the ten largest paralogous gene families
(n$10) revealed that five of these families have probable
transmembrane CDSs and 8 have secretory CDSs (with signal
peptide sequence). Further studies should be conducted to
evaluate the niche-specific pathogenesis-related function of these
genes as well as their potential to provide antigenic diversity when
infecting M. suis confronts the adaptive immune response of the
pig.
Conclusions
Our whole-genome analysis of M. suis provides new insights into
its virulence and pathogenesis, antigenic variation, and gives us a
better understanding of the nutrients and/or metabolites that are
essential for its survival. While we were able to predict metabolic
pathways, gaps remain to be filled and enzyme activities to be
experimentally characterized. Nonetheless, the metabolic map
developed herein will serve as the basis for future attempts to
cultivate this organism in vitro.
Immunomodulatory mechanisms exerted by the M. suis during
chronic infection are still unknown. The presence of large
paralogous gene families should be further investigated in respect
to antigenic variation and immune system evasion. The acute
disease, however, may be exacerbated by a scavenging and
competition mechanism for nutrients and/or metabolites. Overall,
M. suis has a typical Mollicutes genome and is dependent on host
cell metabolism for its survival (hemotrophic not just hemotropic),
a characteristic that is likely to be linked to its pathogenicity.
Materials and Methods
Bacterial strain
The M. suis (E. suis) Illinois strain was obtained from Dr James
Zachary, University of Illinois, Urbana-Champaign, IL [75]. This
strain was initially isolated from a pig with acute bacteremia. The
present study represents the second passage of this bacterium
through experimental infection. Following the first passage of this
strain, EDTA blood was harvested at peak bacteremia and stored
in 1.0 mL aliquots at 280uC.
Experimental infection
One 45-day old, female, mixed-breed pig obtained from the
Purdue Swine Farm was used in this study. The animal was
housed at the Purdue University Animal Care and Use Facilities
and provided feed and water ad libitum. Blood samples that were
collected on days 0 (arrival day at the housing facility), 4 and 7,
were negative for M. suis infection using a species-specific real-time
PCR (Guimaraes et al., unpublished). On day 7 the pig was
splenectomized and 2 weeks later she was experimentally infected
via intravenous injection of 1.0 ml of blood infected with the M.
suis Illinois strain. Approximately 10 days later when a peak of
bacteremia (.90% of red blood cells infected) occurred, blood
samples were collected for M. suis DNA isolation.
Animal use and experimental infection were conducted under a
protocol approved by the Purdue University Animal Care and Use
Committee (Protocol #06-100). To control bacteremia and febrile
episodes, the pig was treated at peaks of M. suis bacteremia with
oxytetracycline (20 mg/kg, intramuscularly, twice daily) and
flunixin meglumine (2.2 mg/kg, intramuscularly, once every
24 h) after blood collection.
DNA extraction
A total of 30 mLs of blood were collected in EDTA containing
tubes and promptly processed as previously described [75,76].
Briefly, the blood was initially centrifuged for 5 min at 1,0006g.
Plasma and buffy coat (white blood cells and platelets) were
removed with a sterile Pasteur pipette. The red blood cells were
resuspended in 3 volumes of 16 PBS-Tween and mixed by
inversion for 4 to 8 hours to allow organisms to detach from the
erythrocytes. Following centrifugation for 5 min at 1,0006g, the
supernatant, which contains detached organisms, was harvested
and filtered with 5.0 mm and 1.2 mm syringe-top filters to
eliminate white blood cells. Organisms were then ultracentrifuged
for 60 minutes at 22,0006 ga t4 uC in sterile tubes; the pellet
resuspended in 16 PBS and extracted using a commercial kit
following manufacturer’s instructions (Quick-gDNA Miniprep,
Zymo Research Corporation, Orange, CA). Quality and quantity
of DNA was assessed by UV spectrophotometry (NanoDrop 2000,
Thermo Scientific, Wilmington, DE, USA). The final quantity
obtained as measured by Pico Green double stranded DNA
fluorimetry was 18.7 mg of DNA; 5 mg of this extracted DNA were
used for sequencing.
DNA sequencing, sequence assembly, gap closure and
validation
Whole-genome sequencing of M. suis was performed at the
Purdue University’s Genomics Core Facility using a GS-FLX (454)
and Titanium chemistry to sequence a 3 kb paired end library.
Mycoplasma suis genomic DNA was initially sheared into 3 kb
fragments using the Hydroshear DNA Shearing Device (Genomic
Solutions, Ann Arbor, Michigan, USA) to create fragments
for paired end libraries. Libraries were then created following
standard procedures from the Roche Paired End Library
Preparation Method Manual. From a quarter PicoTitrePlate
(PTP) GS-FLX run, a total of 55 million bases of sequence com-
prising 395,524 filter-pass sequence reads were generated with an
average read length of 140 bp after removal of adaptor sequence
and splitting of reads into pairs. After removal of adaptor
sequences this came to roughly 55 million bases of sequence.
Reads were assembled using gs-Assembler (Version 2.3) (454
Life Sciences, Roche Applied Science). A total of 6 scaffolds
resulted from this assembly; five of the shorter scaffolds, ranging in
size from 3101 to 5614 bp, were identified as porcine DNA based
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The remaining scaffold (742,116 bp) did not show any significant
BLAST hit to porcine sequences and was identified as M. suis.A
mean genome coverage of 38.6 was obtained. A single gap that
was located in this scaffold was closed with a primer walking
approach and bidirectional sequencing by the Sanger method at
Purdue University’s Genomics Core Facility. The sequence data
was submitted to the NCBI under accession number CP002525
(ADWK01000001). The genome sequence of M. suis was validated
by comparison of virtual fingerprint patterns with that of
fragments derived from pulsed-field gel electrophoresis (PFGE)
of rare cutting restriction enzymes as previously reported [76]. In
addition, a Lambda ZAPII library of M. suis was constructed; the
sequence of 20 inserts (approximately 0.2 to 4.5 kb each) from
immunoreactive clones (data not shown) in this library were
compared to that of the M. suis genomic sequence.
Identification of CDS and annotation
Automated gene prediction was done using Glimmer version
3.02 [77]. Briefly, an initial set of CDSs was identified using
Glimmer (Genetic Code Table 4) and analyzed using the
annotation engine Manatee from The Institute for Genomic
Sciences (University of Maryland, School of Medicine, Baltimore,
MD). CDSs showing a HMM (Hidden Markov Model) score
above the trusted threshold, $45% identity and $90% coverage
to known gene sequences according to BER (BLAST-Extended-
Repraze) were selected. These sequences, in addition to long
CDSs extracted using the Glimmer’s ‘‘long-orfs’’ program, were
subsequently used to train Glimmer 3.02 to recognize potential
CDSs in the whole M. suis genome as a final prediction. DNA
regions not contained in this final prediction set were extracted
using the Glimmer’s ‘‘uncovered’’ program and blasted (blastx)
against non-redundant proteins database from GenBank to allow
for identification of missing CDSs.
The CDSs were again analyzed with Manatee. Individual
CDS were manually curated; evidence generated by the pipeline
(incuding BER, HMMs, PROSITE matches, TMHMM and
SignalP) were used to infer annotations. CDSs with HMM score
below the trusted value and less than 40% identity or only local
similarities to known protein sequences, were called hypothetical
proteins. tRNAs were located using tRNA-scan-SE [78]. Lipo-
proteins and signal peptides were identified using LipoP and
SignalP algorithms, respectively [79–82], and paralogous gene
families were recognized using BLASTCLUST analysis (National
Center for Biotechnology Information, NCBI, Bethesda, MD),
with 30% sequence identity and 70% covered length thresholds.
Comparative analyses with other bacterial genomes were per-
formed based on genome annotations deposited in the NCBI
Genome database.
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